Fracture Risk and Its Prevention Patterns in Korean Patients with Polymyalgia Rheumatica: a Retrospective Cohort Study

被引:3
作者
Nam, Bora [1 ,2 ]
Sung, Yoon-Kyoung [1 ,2 ]
Choi, Chan-Bum [1 ,2 ]
Kim, Tae-Hwan [1 ,2 ]
Jun, Jae-Bum [1 ,2 ]
Bae, Sang-Cheol [1 ,2 ]
Yoo, Dae-Hyun [1 ,2 ]
Cho, Soo-Kyung [1 ,2 ]
机构
[1] Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, 222-1 Wangsimni Ro, Seoul 04763, South Korea
[2] Hanyang Univ, Inst Rheumatol Res, Seoul, South Korea
关键词
Polymyalgia Rheumatica; Fracture; Osteoporosis; Bone Mineral Density; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; RHEUMATISM/AMERICAN COLLEGE; PROGNOSTIC-FACTORS; EUROPEAN LEAGUE; EPIDEMIOLOGY; DISPARITIES; PREVALENCE; MANAGEMENT; DIAGNOSIS; DISEASES;
D O I
10.3346/jkms.2021.36.e263
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To evaluate the incidence of fractures and fracture risk factors in Korean patients with polymyalgia rheumatica (PMR). Methods: All PMR patients who visited a rheumatology clinic at a tertiary referral hospital between March 2005 and March 2018 were retrospectively assessed. We estimated bone mineral density (BMD) screening rate within 6 months of the first visit and classified the patients according to the performance and results of BMD screening. Incidence rates (IRs) of fractures were calculated in each group and risk factors for fractures were identified using Poisson regression analysis. Results: A total of 95 PMR patients with median (interquartile range) age of 64.0 (56.0-72.0) years were included. Baseline BMD was assessed in only 55.8% of these patients (n = 53); 24 patients with osteoporosis, 20 with osteopenia, and 9 with normal BMD. During 433.1 person-years (PYs) of observation, 17 fractures occurred in 12 patients (IR, 3.93 [95% confidence interval (CI), 2.46-6.26]/100 PYs); 8.32 (95% CI, 4.09-16.90)/100 PYs in the osteopenia group, 3.40 (95% CI, 1.30-8.90)/100 PYs in the osteoporosis group, and 3.37 (95% CI, 1.53-7.39)/100 PYs in the no BMD test group. Risk factors for fractures were female sex, advanced age (>_ 65 years), longer follow-up duration, initial glucocorticoid dose >_ 10 mg/day, and higher cumulative glucocorticoid dose over the first 6 months. Conclusion: The incidence rate of fractures in Korean patients with PMR was 3.93/100 PYs. Female sex, advanced age, longer follow-up duration, and increased glucocorticoid dose are risk factors for osteoporotic fracture.
引用
收藏
页数:13
相关论文
共 40 条
  • [1] Predictors of bone density testing in patients with rheumatoid arthritis
    Aizer, J.
    Reed, G.
    Onofrei, A.
    Harrison, M. J.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2009, 29 (08) : 897 - 905
  • [2] [Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1
  • [3] Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective
    Boonen, Steven
    Dejaeger, Eddy
    Vanderschueren, Dirk
    Venken, Katrien
    Bogaerts, An
    Verschueren, Sabine
    Milisen, Koen
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (05) : 765 - 785
  • [4] Glucocorticoid-induced osteoporosis: pathophysiology and therapy
    Canalis, E.
    Mazziotti, G.
    Giustina, A.
    Bilezikian, J. P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 (10) : 1319 - 1328
  • [5] Geographic and ethnic disparities in osteoporotic fractures
    Cauley, Jane A.
    Chalhoub, Didier
    Kassem, Ahmed M.
    El-Hajj Fuleihan, Ghada
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2014, 10 (06) : 338 - 351
  • [6] Gender Differences in Osteoporosis and Fractures
    Cawthon, Peggy M.
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2011, 469 (07) : 1900 - 1905
  • [7] Comorbidity in polymyalgia rheumatica
    Chatzigeorgiou, C.
    Mackie, S. L.
    [J]. REUMATISMO, 2018, 70 (01) : 35 - 43
  • [8] Osteoporosis: Evaluation of Screening Patterns in a Primary-Care Group Practice
    Cohen, Kenneth
    Maier, Diana
    [J]. JOURNAL OF CLINICAL DENSITOMETRY, 2008, 11 (04) : 498 - 502
  • [9] 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
    Dasgupta, Bhaskar
    Cimmino, Marco A.
    Maradit-Kremers, Hilal
    Schmidt, Wolfgang A.
    Schirmer, Michael
    Salvarani, Carlo
    Bachta, Artur
    Dejaco, Christian
    Duftner, Christina
    Jensen, Hanne Slott
    Duhaut, Pierre
    Poor, Gyula
    Kaposi, Novak Pal
    Mandl, Peter
    Balint, Peter V.
    Schmidt, Zsuzsa
    Iagnocco, Annamaria
    Nannini, Carlotta
    Cantini, Fabrizio
    Macchioni, Pierluigi
    Pipitone, Nicolo
    Del Amo, Montserrat
    Espigol-Frigole, Georgina
    Cid, Maria C.
    Martinez-Taboada, Victor M.
    Nordborg, Elisabeth
    Direskeneli, Haner
    Aydin, Sibel Zehra
    Ahmed, Khalid
    Hazleman, Brian
    Silverman, Barbara
    Pease, Colin
    Wakefield, Richard J.
    Luqmani, Raashid
    Abril, Andy
    Michet, Clement J.
    Marcus, Ralph
    Gonter, Neil J.
    Maz, Mehrdad
    Carter, Rickey E.
    Crowson, Cynthia S.
    Matteson, Eric L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (04) : 484 - 492
  • [10] Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study
    Devauchelle-Pensec, Valerie
    Berthelot, Jean Marie
    Cornec, Divi
    Renaudineau, Yves
    Marhadour, Thierry
    Jousse-Joulin, Sandrine
    Querellou, Solene
    Garrigues, Florent
    De Bandt, Michel
    Gouillou, Maelenn
    Saraux, Alain
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (08) : 1506 - 1510